Magnifying LeNS Archives - Page 3 of 6

Immunotherapy Treatment Updates from ASCO 2022: Combinations, Resistance and More

Bethany Johnson (GO2 for Lung Cancer)2022-06-27T06:45:18-05:00June 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program Many patients with non-small cell lung cancer (NSCLC) rely on a class of treatments called immunotherapy to battle their cancer. The significant difference between immunotherapy and targeted therapy (the other [...]

1

Coming Together for Equitable Cancer Care

Bethany Johnson (GO2 for Lung Cancer)2022-06-27T06:39:23-05:00June 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program One of the priorities of GO2 for Lung Cancer, alongside many other ally organizations, is to ensure that people diagnosed with lung cancer receive optimal care regardless of their background, [...]

0

Treatments Beyond Surgery: Early-stage Options from ASCO 2022

Bethany Johnson (GO2 for Lung Cancer)2022-06-27T06:16:53-05:00June 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Authors: Andrew Ciupek, PhD, Associate Director, Clinical Research and Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program People who are diagnosed with early stage (stage 1-2) non-small cell lung cancer (NSCLC) are generally broken down into two groups: those [...]

0

Small Cell Lung Cancer Transformation: What Is It and How Do We Treat It?

Bethany Johnson (GO2 for Lung Cancer)2023-09-20T12:45:20-05:00April 28th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program, GO2 for Lung Cancer People with lung cancer receiving treatment may encounter acquired drug resistance—a reduction in treatment effectiveness over time. Tagrisso (osimertinib) is currently a frontline treatment for people [...]

1

Immune Checkpoint Inhibitor Resistance: What To Do Next?

Bethany Johnson (GO2 for Lung Cancer)2022-04-28T09:02:18-05:00April 28th, 2022|Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program, GO2 for Lung Cancer Immunotherapy, a type of treatment that helps the body’s own immune system fight cancer, is often discussed as a first line of treatment for people with [...]

0

New Screening Guidelines: How They Affect You and What You Need To Know

Bethany Johnson (GO2 for Lung Cancer)2022-04-28T09:00:22-05:00April 28th, 2022|Magnifying LeNS, News, Newsletter Articles, Science and Research|

Authors: Andrew Ciupek, PhD, Associate Director, Clinical Research, GO2 for Lung Cancer; Anita K. McGlothlin, Senior Director, Economics & Health Policy, GO2 for Lung Cancer; Angela Criswell, MA, CPS, Director, Quality Screening and Program Initiatives, GO2 for Lung Cancer [...]

1

Considering Caregivers: The Lung Cancer Registry’s Newest Initiative

Bethany Johnson (GO2 for Lung Cancer)2022-04-28T11:55:54-05:00April 28th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Authors: John Wells, MBA, Senior Specialist, Lung Cancer Registry; Jamie L. Studts, PhD, Professor of Medical Oncology and Scientific Director of Behavioral Oncology, University of Colorado School of Medicine; GO2 for Lung Cancer Scientific Leadership Board Member; International Caregiver [...]

0

New and Improved Lung Cancer Registry

Bethany Johnson (GO2 for Lung Cancer)2022-02-23T10:56:16-06:00February 23rd, 2022|Hot Topics, Magnifying LeNS, News, Newsletter Articles, Science and Research|

First and Only Global Lung Cancer Registry Through its Lung Cancer Registry, GO2 for Lung Cancer securely gathers information from lung cancer patients across the globe - providing researchers with rich data from which to identify trends that can [...]

2

Small Cell Lung Cancer Initiative 2021 Recap and Future Directions

Sarah Wilson2023-09-20T12:45:40-05:00January 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

Authors: Amy Kampschroeder MA, OTR/L, CHES, Manager, Patient Outreach and Special Initiatives and Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program In 2021, one of GO2 for Lung Cancer’s priorities continued to be bringing lung cancer education and empowerment to patients to help [...]

4

Navigating Biomarker Testing Issues

Sarah Wilson2022-01-27T15:58:28-06:00January 27th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Andrew Ciupek, PhD, Senior Manager of Clinical Research Due to the increasing number of approved targeted therapies for the treatment of lung cancer, clinical guidelines recommend that every patient receive comprehensive biomarker testing. Despite the importance of comprehensive [...]

0